| |
Study NO.
|
Prevalencea (95% CI)
|
Weight %
|
|---|
|
Diagnostic method
|
PCR
|
10
|
0.06 (0.04–0.09)
|
45.50
|
|
Serology
|
8
|
0.23 (0.10–0.35)
|
27.90
|
|
Culture
|
6
|
0.17 (0.10–0.24)
|
26.60
|
|
Total
|
24
|
0.13 (0.11–0.24)
|
100
|
|
Study type
|
Case – control
|
9
|
0.16 (0.11–0.21)
|
36.67
|
|
Sectional
|
15
|
0.13 (0.08–0.17)
|
66.33
|
|
Total
|
24
|
0.13 (0.11–0.24)
|
100
|
|
Continent
|
Europe
|
14
|
0.13 (0.09–0.18)
|
59.55
|
|
Asia
|
3
|
0.08 (−0.01–0.17)
|
10.70
|
|
USA
|
6
|
0.15 (0.08–0.22)
|
20.06
|
|
Africa
|
1
|
0.29 (0.23–0.34)
|
3.69
|
|
Total
|
24
|
0.13 (0.11–0.24)
|
100
|
|
Recognize group
|
NO
|
14
|
0.04 (0.02–0.05)
|
57.08
|
|
Yes
|
10
|
0.26 (0.19–0.33)
|
42.92
|
|
Total
|
24
|
0.13 (0.11–0.24)
|
100
|
- aPoint estimate and confidence interval were estimated using random effects model
